Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-02-11 17:19:53 |
Versijas komentārs | |
Teksts |
Olaine, February 11, 2014
„Olainfarm” Announces
Forecasts For 2014
According to preliminary estimates unconsolidated sales of AS
„Olainfarm” in 2014 will reach 80 million euro, while
unconsolidated profit will reach 14 million euro. It is planned
that consolidated sales will reach 90 million euros, while
consolidated profit will be as high as 15 million euro.
AS „Olainfarm” will
continue strengthening its position in chemical intermediate and
API market and plans that sales in this segment will increase to at
least 28 million euros within the next five to seven years. Last
year the sales in this segment were slightly above 5 million
euro.
This year AS „Olainfarm” will focus on penetration into Central
Asian markets of Tajikistan,
Turkmenistan, Kyrgyzstan and Uzbekistan. The task is to make
a full use of having representative offices there. Among other
things, the company intends to use its experience and capacity to
increase CIS exports of Latvian food supplement producer SIA
„Silvanols”, controlling stake in which was acquired by AS
„Olainfarm” last year.
During 2014 AS “Olainfarm” plans to make a capital investment of at
least 13 million euro. During this and the next four years it is
planned to build a new production unit of nitrofuranes, increase
capacity of final dosage form production, reconstruct the
wastewater system, improve energy efficiency, and invest in
chemical production and quality assurance systems.
A/s OlainFarm is one of
the biggest pharmaceutical companies in Latvia with 40 years of
experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 30 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia. Information
prepared by:
|
Pielikumi |
|